WC
XGN icon

Wexford Capital’s Exagen XGN Stock Holding History

Wexford Capital’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Buy
792,855
+326,077
+70% +$1.26M 0.34% 35
2025
Q4 		$2.84M Buy
466,778
+21,851
+5% +$199K 0.55% 33
2025
Q3 		$4.89M Buy
444,927
+28,579
+7% +$253K 0.7% 19
2025
Q2 		$2.91M Buy
+416,348
New +$2.53M 0.81% 21

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Wexford Capital's XGN Position: Q1 2026 in Review

Wexford Capital increased its Exagen (XGN) stake by 70% in Q1 2026, buying an estimated $1.26M and bringing the position to 792,855 shares worth $2.38M. The position accounts for 0.34% of the portfolio, ranked #35.

Wexford Capital first reported a position in XGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.89M in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Wexford Capital held 792,855 shares of Exagen worth $2.38M as of Q1 2026.
  • Wexford Capital bought 326,077 Exagen shares in Q1 2026, an estimated $1.26M.
  • Exagen made up 0.34% of Wexford Capital's portfolio in Q1 2026, its #35 holding.
  • Wexford Capital first reported a position in Exagen in Q2 2025 and has held it in 4 quarters since.
  • Wexford Capital's Exagen position peaked at $4.89M in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Wexford Capital's 13F filing for Q1 2026, filed 15 May 2026.